Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vaxart, Inc

0.3955
-0.0085-2.10%
Post-market: 0.40000.0045+1.14%19:45 EDT
Volume:1.25M
Turnover:501.49K
Market Cap:90.26M
PE:-1.48
High:0.4100
Open:0.4050
Low:0.3901
Close:0.4040
Loading ...

BRIEF-Vaxart Announces Adjournment Of Annual Meeting Of Stockholders

Reuters
·
03 Jun

Vaxart Inc - Adjourns Annual Meeting to June 13, 2025

THOMSON REUTERS
·
03 Jun

Vaxart Inc: Engaged in Conversations With Some Larger Stockholders About Reverse Stock Split Proposal

THOMSON REUTERS
·
03 Jun

Press Release: Vaxart Announces Adjournment of Annual Meeting of Stockholders

Dow Jones
·
03 Jun

Vaxart’s Founder and Chief Scientific Officer Provides Video Update to Stockholders

THOMSON REUTERS
·
29 May

Vaxart Inc - Board Commits to High End of 1-for-20 Reverse Stock Split Ratio - SEC Filing

THOMSON REUTERS
·
29 May

Vaxart Inc - Board Believes More Time Needed for Voting Considering the Potential Delisting From Nasdaq - SEC Filing

THOMSON REUTERS
·
29 May

Vaxart Inc. Proposes Reverse Stock Split to Regain Nasdaq Compliance

Reuters
·
29 May

Vaxart Secures Up to $460.7 Million Funding from Project NextGen for Oral COVID-19 Vaccine Development

Reuters
·
28 May

BRIEF-Vaxart Initiates Dosing In 10,000-Participant Portion Of Phase 2B Covid-19 Trial

Reuters
·
27 May

Vaxart doses first patient in 10,000-participant part of COVID-19 trial

TIPRANKS
·
27 May

Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2B Covid-19 Trial

THOMSON REUTERS
·
27 May

Press Release: Vaxart Announces Adjournment of Annual Meeting of Stockholders

Dow Jones
·
22 May

Vaccine Stocks Surge with Moderna up 11%

Tiger Newspress
·
20 May

Vaxart Inc. Files Initial Statement of Beneficial Ownership for CFO Jeroen Grasman

Reuters
·
20 May

Steven Lo, President and CEO, Reports Acquisition of Common Shares in Vaxart Inc

Reuters
·
20 May

Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting

THOMSON REUTERS
·
16 May

Press Release: Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting

Dow Jones
·
16 May

Vaxart receives BARDA approval to initiate dosing of Phase 2b COVID-19 trial

TIPRANKS
·
15 May

Vaxart Receives Barda Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2B Covid-19 Trial

THOMSON REUTERS
·
15 May